KEGG   DRUG: D08874Help
Entry
D08874                      Drug                                   

Name
Bevasiranib sodium (USAN)
Formula
C401H463N153Na40O290P40
Exact mass
14218.1598
Mol weight
14224.3593
Activity
Treatment of wet age-related macular degeneration
Comment
siRNA inhibitor of Vascular Endothelial Growth Factor (VEGF) production
angiogenesis inhibitor
Target
VEGF-A mRNA [HSA:7422] [KO:K05448]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04370  VEGF signaling pathway  
 
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines
  PDGF family
   VEGFA
    Bevasiranib
     D08874  Bevasiranib sodium (USAN)
BRITE hierarchy
Other DBs
CAS: 
849758-52-7
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system